| Ident. | Authors (with country if any) | Title |
|---|
| 000390 (2014) |
Erwan Bezard [République populaire de Chine] ; Elsa Y. Pioli ; Qin Li ; Françoise Girard ; Vincent Mutel ; Charlotte Keywood ; Francois Tison ; Olivier Rascol ; Sonia M. Poli | The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model. |
| 000496 (2014) |
Alberto J. Espay [États-Unis] ; Peter A. Lewitt ; Horacio Kaufmann | Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement. |
| 000683 (2014) |
Eduardo Tolosa [Espagne] ; Irene Litvan ; Günter U. Höglinger ; David Burn ; Andrew Lees ; María V. Andrés ; Belén G Mez-Carrillo ; Teresa Le N ; Teodoro Del Ser | A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. |
| 000767 (2013) |
Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. |
| 000787 (2013) |
Karen L. Eskow Jaunarajs [États-Unis] ; David G. Standaert ; Tacey X. Viegas ; Michael D. Bentley ; Zhihao Fang ; Bekir Dizman ; Kunsang Yoon ; Rebecca Weimer ; Paula Ravenscroft ; Tom H. Johnston ; Michael P. Hill ; Jonathan M. Brotchie ; Randall W. Moreadith | Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit. |
| 000814 (2013) |
Rupam Borgohain [Inde] ; J. Szasz [Roumanie] ; P. Stanzione [Italie] ; C. Meshram [Inde] ; M. Bhatt [Inde] ; D. Chirilineau [Roumanie] ; F. Stocchi [Italie] ; V. Lucini [Italie] ; R. Giuliani [Italie] ; E. Forrest [Italie] ; P. Rice [États-Unis] ; R. Anand [Suisse] | Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations |
| 000928 (2013) |
Ganesvaran Ganga [Australie] ; Jane E. Alty ; Benjamin G. Clissold ; Craig D. Mccoll ; Katrina A. Reardon ; Mark Schiff ; Peter A. Kempster | Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase. |
| 001397 (2011) |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group [Allemagne, Afrique du Sud, Pologne, Hongrie, États-Unis, Nouvelle-Zélande, Finlande, Royaume-Uni, Italie, Espagne, Autriche] | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
| 001579 (2011) |
Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne] | Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease |
| 001674 (2011) |
Martin Köllensperger [Autriche] ; Florian Krismer [Autriche] ; Anton Pallua [Autriche] ; Nadia Stefanova [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy |
| 001681 (2011) |
Giovanni Albani [Italie] ; Nadia El Assawy [Italie] ; Stefania Cattaldo [Italie] ; Marilena De Gennaro [Italie] ; Francesca Gregorini [Italie] ; Luca Pradotto [Italie] ; Alessandro Mauro [Italie] | Electrogastrographyc activity in Parkinson's disease patients with and without motor fluctuations |
| 001944 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada] | The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates |
| 001A99 (2010) |
Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets |
| 001B22 (2010) |
Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Andrew Christopher Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP‐treated common marmosets |
| 001B92 (2010) |
Emanuele Cereda [Italie] ; Michela Barichella [Italie] ; Carlo Pedrolli [Italie] ; Gianni Pezzoli [Italie] | Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review |
| 002025 (2009) |
Julia Vaamonde [Espagne] ; José M. Flores [Espagne] ; Roberto Weisser [Espagne] ; Ram N Iba Ez [Espagne] ; José A. Obeso [Espagne] | The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease |
| 002083 (2009) |
Luigi M. Romito [Italie] ; Maria Fiorella Contarino [Italie] ; Nicola Vanacore [Italie] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Alberto Albanese [Italie] | Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: Long‐term observation |
| 002227 (2009) |
Jane E. Alty [Australie] ; Benjamin G. Clissold [Australie] ; Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie] | Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function |
| 002251 (2009) |
Jan Herzog [Allemagne] ; Bettina Möller [Allemagne] ; Karsten Witt [Allemagne] ; Marcus O. Pinsker [Allemagne] ; Günther Deuschl [Allemagne] ; Jens Volkmann [Allemagne] | Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease |
| 002327 (2009) |
Tobias B Umer [Allemagne] ; Ute Hidding [Allemagne] ; Wolfgang Hamel [Allemagne] ; Carsten Buhmann [Allemagne] ; Christian K. E. Moll [Allemagne] ; Christian Gerloff [Allemagne] ; Michael Orth [Allemagne] ; Hartwig Roman Siebner [Allemagne] ; Alexander Münchau [Allemagne] | Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease |
| 002362 (2009) |
Bruno Fimm [Allemagne] ; Ines A. Heber [Allemagne] ; Volker A. Coenen [Allemagne] ; Christoph Fromm [Allemagne] ; Johannes Noth [Allemagne] ; Martin Kronenbuerger [Allemagne] | Deep brain stimulation of the subthalamic nucleus improves intrinsic alertness in Parkinson's disease |
